Singapore

From having your audio interrupted to your data being wiped out, researchers highlight the security limitation of Bluetooth technology implementations.

Speakers announced for the 10th edition of IPI’s premier technology matching event

The finding could underpin a “dream” vaccine that covers not only SARS-CoV-2 and its known variants of concern (VOCs), but also future VOCs and other animal coronaviruses with known potential to cause severe disease in humans

Scientists in Singapore are calling for revisions in planned hydropower expansions in light of the rapidly decreasing cost of solar photovoltaic systems

Lonely older adults live at least three fewer years, in poorer health, and are less active than non-lonely peers, say ageing research experts.

GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK), a world-leading life sciences research and application service and product provider, and Duke-NUS Medical School, a premier, research intensive medical school, announced today that the U.S. Patent and Trade Office has issued a notice of allowance for the patent application for a novel Surrogate Virus Neutralisation Technology (sVNT). Neutralising antibodies have been scientifically shown to play major role in preventing infection by blocking the virus from infecting the cells.

A signalling protein thought to be able to treat liver damage in paracetamol toxicity could actually worsen it. Instead, Singapore scientists discovered, blocking its effects could be the way forward.

Cryo-electron microscopy and computer simulations uncover how a cellular protein helps transport omega-3 fatty acids to the brain and eye, with implications for drug development.

• Glioblastoma (GBM) is a highly aggressive type of brain cancer. Even with current standard of care, 50% of patients die within 15 months of diagnosis. • This complex cancer is difficult to treat due to its location, structure, ability to spread quickly, high recurrence rate and severely limited treatment options. • GBM tumours can look identical under the microscope but respond differently to the same treatment. • With a national grant of about S$10 million, researchers in Singapore are working with overseas collaborators to address these challenges and develop new diagnostic and treatment options so patients can receive effective targeted therapy.

Single-cell gene studies are clarifying the roles of the brain’s specialised immune cell in Alzheimer’s disease and offer new avenues for treatment of this incurable condition.

The UK’s COP26 Universities Network and leading research centres in Singapore have announced a partnership to develop four reports that provide policy recommendations for climate action in the ASEAN region.

Researchers at the National University of Singapore and Tohoku University have demonstrated that an array of electrically connected spintronic devices can harvest a 2.4 GHz wireless signal, which can be used to power and charge small electronic devices and sensors.

First-of-its-kind in Singapore, the clinical trial will test a technology that enables specific cell therapy products to be manufactured for use in patients.

• Only 20% of primary liver cancer or hepatocellular carcinoma (HCC) are diagnosed at an early stage, which makes early detection an urgent, unmet healthcare need. • Study aims to develop more accurate diagnostics for early HCC, an AI algorithm to predict an individual’s risk of developing HCC, and discover novel molecular targets to prevent the development of HCC. • Study aims to recruit 2,000 participants at high risk of developing HCC from six healthcare institutions and eight polyclinics across Singapore.

The National Supercomputing Centre (NSCC) Singapore has awarded the tender for the development of the next generation national supercomputer system plus upgrades to the national storage and research network infrastructure. The new system is expected to provide up to 10 Petaflops (10 PFLOPS) of computing capacity and is eight times more powerful than the current supercomputer. The new supercomputer is the first in a series of systems that will form the backbone of the nation’s future supercomputing resources which will support research in areas like climate change, biomedical science and smart nation activities.

A mitochondrial peptide called MOCCI has a surprising sidekick, and they work together to regulate inflammation and immunity, Singapore researchers reveal.

A five-year study in Singapore has highlighted that chronic wounds among patients with diabetic foot ulcers and bed sores led to longer hospital stays.

New national body established to further research insights, improve patient outcomes and create new economic opportunities for the biomedical technology industry.

Multi-country trial finds low-cost intervention to improve hypertension management in rural communities is cost-effective. Consisting of home visits by community healthcare workers, physician training and coordination with public health care infrastructure, the intervention can be scaled up in low- and middle-income countries.

Professor David Matchar and his team from the Health Services and Systems Research (HSSR) Programme at Duke-NUS bagged two prestigious awards at the International Stroke Conference 2021, held virtually on 17-19 March, 2021.

Study shows that antibody longevity varies widely from 40 days to as long as several decades and not everyone who has recovered from COVID-19 is immune from reinfection. Individuals with low levels of neutralising antibodies may still be protected if they have robust T-cell immunity. Blood tests and a computer algorithm suggest annual vaccinations might be needed for some individuals to prevent future outbreaks of COVID-19.

New research from Duke-NUS Medical School, and the Agency for Science, Technology and Research identifies chemotherapy-resistant cancers’ escape mechanism, which offers new anti-cancer treatment options.

The SupercomputingAsia 2021 (SCA21) conference reflects this spirit of collaboration with a number of initiatives. These include the signing of a Memorandum of Understanding (MOU) that will create a new link between Singapore entities and Finland’s CSC-IT Centre for Science, the launch of the inaugural HPC Centre Leaders Forum, and the first EU-ASEAN-Japan Symposium.

A brain enzyme activates dormant neural stem cells, revealing how defects in its gene could lead to neurodevelopmental disorders.

COVID-19 has led to psychological distress among one in three adults, large-scale meta-analysis by researchers at Duke-NUS Medical School, Singapore, reveals.

New ‘armoured’ T cells attack cancer without being suppressed by drugs given to transplant patients to avoid organ rejection.

Preventing Wnt from hitching a ride may offer new avenue for novel treatments for cancer and fibrosis.

The SNEC 15th (2021) International Photovoltaic Power Generation and Smart Energy Conference will be held on June 2-4, 2021 in Shanghai, China.

New collaboration between Japan’s RIKEN Center for Computational Science (R-CCS), Research Organization for Information Science and Technology (RIST) and National Supercomputing Centre (NSCC) Singapore, will allow Singapore scientists to directly tap on Japan’s Fugaku supercomputer to do ground breaking research, enhance educational activities and develop talent in high performance computing (HPC).

Cell ID Pte. Ltd., a Singapore-incorporated med-tech company, is selling a palm-sized portable genetic test kit that uses an app on a laptop to detect, anywhere, at any time, if a person has COVID-19.